<DOC>
	<DOC>NCT00276315</DOC>
	<brief_summary>To compare the effectiveness and safety of Dysport® with the domestic Botulinum Toxin Type A (manufactured by Lanzhou Biologic Product Institute, P.R. China) for the treatment of hemifacial spasm.</brief_summary>
	<brief_title>Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm</brief_title>
	<detailed_description />
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Hemifacial Spasm</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Patient suffering from hemifacial spasm with at least 6 months duration (prior to visit 1) Cohen scale ≥ to grade II Botulinum toxin type A treatment history within last 16 weeks prior to visit 1 Hemifacial spasm secondary to facial palsy Previous alcohol or phenol injections or surgical therapy of the facial muscles Requirement for botulinum toxin injection to site(s) of the body other than in this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>